HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A case of sinonasal teratocarcinosarcoma treated with surgery and post-operative intensity-modulated radiotherapy (IMRT).

Abstract
Sinonasal teratocarcinosarcoma (SNTCS) is a rare and aggressive malignant neoplasm, which has poor prognosis. SNTCS is histologically characterized by the combination of one or more epithelial elements and mesenchymal components. We report a 59-year-old man with SNTCS involving right maxillary and ethmoid sinuses. He complained of numbness of the right cheek for 1 month. Computed tomography and magnetic resonance imaging revealed soft tissue filling the right maxillary and ethmoid sinuses, protruding into the nasal cavity. Tumor was removed with Denker rhinotomy, and post-operative intensity-modulated radiation therapy (IMRT: 64Gy in 32 fractions) was performed. Follow-up examination for 2 years after the IMRT has shown no evidence of recurrence or metastasis. IMRT is a new type of conformal radiotherapy that is based on the use of non-uniform radiation beam intensities. IMRT can achieve optimal dose distributions and may improve the clinical outcomes dramatically with minimal complications. This report describes this patient's clinical course, etiology, diagnosis and management of SNTCS, and the advantage of IMRT in the treatment of SNTCS.
AuthorsTakahiro Tokunaga, Hiroshi Sunaga, Yuichi Kimura, Gota Tsuda, Shigeharu Fujieda
JournalAuris, nasus, larynx (Auris Nasus Larynx) Vol. 39 Issue 6 Pg. 641-5 (Dec 2012) ISSN: 1879-1476 [Electronic] Netherlands
PMID22361412 (Publication Type: Case Reports, Journal Article)
CopyrightCopyright © 2012 Elsevier Ireland Ltd. All rights reserved.
Topics
  • Carcinosarcoma (radiotherapy, surgery)
  • Combined Modality Therapy
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Nose Neoplasms (radiotherapy, surgery)
  • Radiotherapy, Intensity-Modulated (methods)
  • Teratoma (radiotherapy, surgery)
  • Tomography, X-Ray Computed
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: